Phase II Clinical Trial of Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
Phase of Trial: Phase I/II
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Bavituximab (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Therapeutic Use
- 16 Jun 2017 Status changed from not yet recruiting to recruiting.
- 03 May 2017 Status changed from planning to not yet recruiting.
- 13 Mar 2017 This trial is on track to be initiated by mid-calendar 2017, according to a Peregrine Pharmaceuticals media release.